[Current developments in the long-term therapy of Parkinson syndrome].
In the course of long-term treatment of Parkinson's disease many problems, which cannot yet be satisfactorily solved, arise with time in a large number of patients. This overview describes some strategies which are used nowadays to tackle these problems. Special attention is drawn to the treatment of painful dystonias and off-periods with apomorphine.
Ludin
H P
HP
Klinik für Neurologie, Kantonsspital, St. Gallen.
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004361:Drug Tolerance; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D014202:Tremor / Q000139:chemically induced
D000978:Antiparkinson Agents
Neuere Entwicklungen in der Langzeitbehandlung des Parkinsonsyndroms.